Antipodes Partners
IQV icon

Antipodes Partners’s IQVIA IQV Stock Holding History

Antipodes Partners’s Portfolio IQV Stock Details IQV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18K Buy
+67
New +$16.2K ﹤0.01% 140

Other funds holding IQV

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Antipodes Partners's IQV Position: Q3 2026 in Review

Antipodes Partners opened a new position in IQVIA (IQV) in Q3 2026: 67 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #140 among its holdings.

984 funds tracked by Wall St. Rank hold IQV as of Q3 2026.

  • Antipodes Partners held 67 shares of IQVIA worth $18K as of Q3 2026.
  • IQVIA was a new Antipodes Partners position in Q3 2026.
  • IQVIA made up ﹤0.01% of Antipodes Partners's portfolio in Q3 2026, its #140 holding.
  • 984 funds tracked by Wall St. Rank held IQVIA as of Q3 2026.

Based on Antipodes Partners's 13F filing for Q3 2026, filed 5 Nov 2026.